Advances in multimodality therapy for hepatocellular carcinoma
Primary liver cancer is one of the most common malignances worldwide, among which hepatocellular carcinoma (HCC) accounts for about 90% of all cases. Multidisciplinary multimodality therapy involving surgery, ablation, interventional treatment, targeted therapy, and immunotherapy is an effective str...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Department of Journal of Clinical Hepatology
2020-10-01
|
| Series: | Linchuang Gandanbing Zazhi |
| Online Access: | http://www.lcgdbzz.org/qk_content.asp?id=11089 |